March 11, 2026

Older RSV Hospitalization Linked to Pneumonia

Large Swedish cohort study finds children hospitalized for respiratory syncytial virus at older ages have greater risk of subsequent bacterial pneumonia

Conexiant

March 10, 2026

Study Maps US States Most Vulnerable to Flu

Machine learning analysis identifies 11 jurisdictions—including the District of Columbia, Massachusetts, and Hawaii—with the highest vulnerability to influenza-like illness.

Conexiant

March 09, 2026

Which Viruses Hit Kids Hardest?

Study compares pathogen type, comorbidities, and clinical severity in pediatric admissions

Conexiant

March 04, 2026

Pneumonia Patterns Postpandemic

Pneumococcal and RSV RAD-CAP incidence increased as SARS-CoV-2 incidence declined, disproportionately affecting older adults.

Conexiant

February 27, 2026

ACOG Parts Ways With ACIP

“ACOG’s withdrawal from ACIP is not a withdrawal from our commitment to advancing vaccine science or to protecting patients’ health and safety."

Conexiant

February 11, 2026

AMA Backs Structured Vaccine Review

Medical societies and public health groups will collaborate on policy questions and evidence briefs for the 2026 to 2027 respiratory virus season.

Conexiant

January 27, 2026

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

Conexiant

February 10, 2026

When Obesity Meets Infection Risk

Researchers analyze data from Finnish cohorts and the UK Biobank to examine how body mass index relates to severe infections and their global burden.

Conexiant

February 02, 2026

Atypical Testing in the Viral Era

Study questions routine testing for atypical bacterial co-infection in viral respiratory hospitalizations

Conexiant

April 24, 2023

Hitting a Moving Target

Flu is a protean creature. How can we pin it down?

The Medicine Maker